United States Clinical Trials Support Services Market Forecast 2022-2028

The United States clinical trials support services market is set to surge with a 7.32% CAGR during the forecast period, 2022-2028. The presence of numerous global companies and the availability of different registered studies drive the market growth in the country.

MARKET INSIGHTS

Support services are the solutions or services provided to the people or organization to execute and complete the clinical trial efficiently. Therefore, Clinical trial support services are the services that help in optimizing the trial process. Support services make the trial process efficient, from data management to data analysis. The key players offer various services like clinical trial management, data management, site management, biostatistics, etc.

The United States is the hub of clinical trials as most companies offering clinical trial support services have their headquarters in the United States. There has been a significant rise in the number of registered studies for clinical trials, as in the year 2000, 2,119 registered studies were available. However, by 2022 the number has increased, and by 8th June 2022, a total of 4,17,874 registered studies are available. Different registered studies, such as medical devices, drug or biological, surgical procedures, etc., are available, which supports the demand for clinical trials support services in the United States.

COMPETITIVE INSIGHTS

Leading players in the market include: Syneos Health, Parexel, Charles River Laboratories Inc, IQVIA, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 47752

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES

3. KEY ANALYTICS

3.1. IMPACT OF COVID -19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
3.2. PESTLE ANALYSIS - UNITED STATES
3.3. KEY MARKET TRENDS
3.4. PORTER'S FIVE FORCES ANALYSIS
- 3.4.1. BUYERS POWER
- 3.4.2. SUPPLIERS POWER
- 3.4.3. SUBSTITUTION
- 3.4.4. NEW ENTRANTS
- 3.4.5. INDUSTRY RIVALRY
3.5. OPPORTUNITY MATRIX
3.6. VALUE CHAIN ANALYSIS
- 3.6.1. SOLUTION PROVIDERS
- 3.6.2. SERVICE PROVIDERS
- 3.6.3. END-USER INDUSTRIES
3.7. KEY BUYING CRITERIA
- 3.7.1. PERFORMANCE
- 3.7.2. EASE OF USE
- 3.7.3. SECURITY
- 3.7.4. COST EFFECTIVENESS
3.8. REGULATORY FRAMEWORK

4. MARKET BY PHASE

4.1. PHASE I
4.2. PHASE II
4.3. PHASE III
4.4. PHASE IV

5. MARKET BY SPONSOR

5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS

6. MARKET BY SERVICE

6.1. CLINICAL TRIAL SITE MANAGEMENT
6.2. ADMINISTRATIVE STAFF
6.3. PATIENT RECRUITMENT MANAGEMENT
- 6.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
- 6.3.2. PATIENT RETENTION
- 6.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
6.4. IRB
6.5. DATA MANAGEMENT
6.6. OTHER SERVICES

7. COMPETITIVE LANDSCAPE

7.1. KEY STRATEGIC DEVELOPMENTS
- 7.1.1. MERGERS & ACQUISITIONS
- 7.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 7.1.3. PARTNERSHIPS & AGREEMENTS
- 7.1.4. BUSINESS EXPANSIONS & DIVESTITURES
7.2. COMPANY PROFILES
- 7.2.1. CHARLES RIVER LABORATORIES INC
- 7.2.2. CLINIPACE
- 7.2.3. IQVIA
- 7.2.4. LABCORP DRUG DEVELOPMENT
- 7.2.5. MEDPACE
- 7.2.6. PAREXEL
- 7.2.7. SYNEOS HEALTH

Product Code: 47752

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 10: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 12: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 14: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 16: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 7: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 8: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 9: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 10: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 11: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 12: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 13: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 14: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 15: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 16: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 17: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2028 (IN $ MILLION)
FIGURE 18: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 19: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 20: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 21: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2028 (IN $ MILLION)
FIGURE 22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 23: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2028 (IN $ MILLION)
FIGURE 24: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 25: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)